Business Context and Reporting Period
Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 6, 2023
Reporting Period: Single event date (February 6, 2023)
Business Context: The filing discloses a video interview conducted by CEO Dr. Anatoly Dritschilo with Proactive Investors. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
This filing is a Regulation FD disclosure regarding a media interview and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material changes to financial position or operations are reported in this document. The filing serves solely to disclose the availability of a video interview.
Guidance, Outlook, and Risks
- Management Commentary: The CEO participated in a video interview available on the Proactive Investors website and YouTube.
- Disclosure Channels: The Company utilizes its website, press releases, and social media channels (including YouTube) to disclose public information.
- Materiality Disclaimer: The Company makes no admission as to the materiality of the information contained in the interview solely by reason of Regulation FD.
- Legal Status: The information furnished in Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the content of the CEO interview at the provided YouTube link (https://youtu.be/K-QFWPG2OoU) for potential material updates not detailed in this 8-K.
- Review the Company's website and social media channels for additional disclosures deemed material by management.
- Confirm the Company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.